UnitedHealth: It's Time To Buy This Recovery

I still view UnitedHealth as a fully playable recovery, with MCR improving from 89.4% to 86.7% and 2026 EPS guidance already raised twice. Management is deliberately giving up lower-quality membership to rebuild margins, while operating cash flow guidance has increased from >$18B to ~$24B. The broader health care setup also looks attractive, with the sector heavily lagging the S&P 500 and a more defensive macro backdrop developing. At roughly 18.7x 2026 EPS, I believe UNH still prices in too little of management’s 13%-16% long-term EPS growth ambition.

UnitedHealth Group Incorporated ( UNH ) has been one of my highest-conviction contrarian calls over the past year, with the stock performing very well since each rating. The setup deteriorated sharply in 2025: Q2 2025 MCR This article was written by Cyn Research 1.13K Followers Follow Hi! I'm a passionate investor who has been researching publically traded companies for over 8 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term but I also dive into trend following strategies from time to time. While I have a slight bias toward technology companies, I maintain a broad perspective, including opportunities in crypto. I take a global approach to investing, occasionally seeking value beyond the U.S. market. Thanks for reading! Analyst’s Disclosure: I/we have a beneficial long position in the shares of UNH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.